Objective: Mitochondrial permeability transition pore opening is associated with apoptotic signaling and alterations in mitochondrial structure and function. We tested whether inhibition of mitochondrial permeability transition pore opening with cyclosporine A preserved mitochondrial structure and function after cardioplegic arrest and whether this preservation is associated with improved myocardial performance.
Results: In comparison with non-CCP, CCP was associated with Bax translocation to the mitochondria, cytochrome c release, and greater frequency of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive myocytes These changes were also associated with deficits in isolated mitochondrial oxygen consumption at complex I. CsA pretreatment minimized or prevented all these findings. Myocardial performance (systolic pressure, maximum positive and negative dP/dt, and elevated left ventricular end-diastolic pressure) at 5, 15, 30, and 60 minutes after reperfusion was diminished in CCP hearts when compared with non-CPB, and these deficits could be minimized with cyclosporine A pretreatment. (P , .05 all comparisons)
Conclusions: Cyclosporine A prevents apoptosis-related mitochondrial permeabilization and dysfunction after cardioplegic arrest. This protection is associated with improved myocardial performance. Prevention of mitochondrial permeability transition pore opening is a valuable target for mitochondrial (and myocardial) preservation after neonatal cardioplegic arrest.
A s a critical mediator in apoptosis signaling pathways, mitochondria integrate upstream death stimuli and undergo structural and functional remodeling with subsequent transmission of signals to downstream executioner proteins. 1 Bax translocation, mitochondrial outer membrane permeabilization, and cytochrome c release directly participate in mitochondrial architectural and functional remodeling after unprotected ischemia/reperfusion. [2] [3] [4] After protected ischemia/reperfusion (cardioplegic arrest), we have previously reported a similar constellation of apoptosis-related alterations in mitochondrial structure and function in the lamb and piglet myocardium (apoptosis-related mitochondrial dysfunction: ARMD). [5] [6] [7] We correlated these changes with deficits in mitochondrial electronic transport chain activity. 8, 9 Because of the close interplay between apoptotic events and mitochondrial dysfunction, as well as the role of mitochondrial protection in the maintenance of cardiac performance, 10 we hypothesized that ''mitoprotection'' conferred by maintenance of outer mitochondrial membrane integrity may be of therapeutic benefit to reduce ARMD and consequently preserve myocardial performance.
The mitochondrial permeability transition pore (MPTP) is a nonspecific pore that may mediate alterations in outer mitochondrial membrane integrity. Pharmacologic inhibition of MPTP opening is associated with myocardial protection against unprotected ischemia/reperfusion injury. 13, 14 Cyclosporine A (CsA), a specific inhibitor of MPTP opening, acts by inhibiting the peptidyl-prolyl cis-trans isomerase activity of the cyclophilin-D component of the MPTP and has been reported to ameliorate reperfusion injury in a variety of in vitro 15, 16 and in vivo 17 animal models of unprotected and protected ischemia. 7, 18 We 7 have previously reported that CsA-mediated MPTP pore inhibition prevents ARMD in a neonatal piglet model. This report extends these observations in a neonatal rabbit model and relates amelioration of ARMD to preservation of global myocardial performance.
Methods and Materials

Experimental Model
New Zealand White neonatal rabbits (5-6 days; 150-250 g) were anesthetized with sodium pentobarbital (50 mg/kg intraperitoneally), heparinized (1000 U/kg intraperitoneally), and ventilated. The heart was retrogradely perfused in situ to avoid ischemia, excised, mounted on a Langendorff perfusion system, and perfused at 75 mm Hg with Krebs-Henseleit buffer (KH) equilibrated with 95% oxygen and 5% carbon dioxide (pH of 7.35-7.40).
All animals received humane care in compliance with the ''Guide for the Care and Use of Laboratory Animals'' prepared by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC; March 1999).
Experimental Protocol
Two groups of hearts were perfused for a 30-minute stabilization period followed by 60 minutes of crystalloid cardioplegic arrest (CCP) and 60 minutes of reperfusion. During the stabilization period, cyclosporine A (CsA)-treated hearts (CCP1CsA group, n 5 6) were perfused with KH in which CsA (0.2 mmol/L) was added to the KH. Nontreated hearts (CCP, n 5 6) were stabilized with KH perfusion alone. Cardioplegic arrest for both groups was induced with crystalloid cardioplegia (65 mL/kg, Plegisol; Hospira, Inc, Lake Forest, Ill) at normothermia. 19 CsA was dissolved in dimethylsulfoxide (Fisher Scientific, Waltham, Mass), which was further dissolved into KH at a final concentration of 0.05%. The same amount of dimethylsulfoxide was added into the KH for all other groups.
A third group of hearts underwent uninterrupted perfusion (non-CCP, n 5 6) for 150 minutes.
At the end of reperfusion, the hearts were rapidly excised. For mitochondrial oxygen consumption and mitochondrial protein extraction, myocardium was fractionated as described. 8 A separate set of animals (n 5 4 for each group) underwent identical procedures after which the left ventricles were sliced and embedded in OCT compound (IMEB, Inc, San Marcos, Calif), snap frozen in liquid nitrogen, and stored at 280 C for apoptosis and fluorescence immunohistochemistry.
Cardiac Functional Measurements
Isovolumetric measurement of left ventricular (LV) performance was made with a water-filled balloon connected to a pressure transducer (MLT844; ADInstruments, Colorado Springs, Colo) and inserted into the left ventricle across the mitral valve. The volume of the water-filled balloon was adjusted to an end-diastolic pressure of 0 to 5 mm Hg and kept constant throughout the entire experiment. LV performance was assessed with LV systolic pressure, LV enddiastolic pressure, LV developed pressure, and maximum positive and negative derivative of LV pressure (6dP/dtmax). Analog data (heart rate and LV systolic pressure, developed pressure, enddiastolic pressure, and 6dP/dtmax) were digitalized and analyzed (Chart IV; ADInstruments, Colorado Springs, Colo). Hemodynamic data were compared at comparable time points in all three groups.
Mitochondrial Isolation
The left ventricle was used for mitochondrial isolation by differential centrifugation. 20 The whole left ventricle (0.7 g) was placed into 5 mL of mitochondrial isolation buffer (MIB) on ice (5 mmol/L MOPS, 2 mmol/L ethylene glycol bis-2-aminoethyl ether-N,N',N'',n'-tetraacetic acid, 70 mmol/L sucrose, 220 mmol/L mannitol, 1 mmol/L dithiothreitol, 17 mg/mL phenylmethylsulfonyl fluoride, 8 mg/mL aproptinin, and 2 mg/mL leupeptin, pH 7.2) with 0.1% bovine serum albumin (BSA) and finely minced. Tissue was homogenized on ice by a blade homogenizer and centrifuged (700g 3 5 minutes). The supernatant was transferred to a new tube and the same low spin repeated four times (5 minutes each) until no visible pellet was seen. The supernatant from the low spins was centrifuged (8000g 3 10 minutes). The pellet was resuspended in 10 mL MIB with 0.1% BSA and centrifuged for another 10 minutes (8000g). The final pellet was suspended in MIB buffer without BSA for mitochondrial oxygen consumption measurements.
Clark-electrode Oxygen Consumption Measurement
Mitochondrial complex I, II, and IV respiration was measured with a Clark-type oxygen electrode (Instech Laboratories Inc, Plymouth Meeting, Pa). Oxygen consumption was measured in the presence of sequential administration of substrates and inhibitors (glutamate/ malate for complex I, rotenone/succinate for complex II, Images from at least three different sections were acquired at 643 by a Zeiss LSM510 Multiphoton Laser Scanning Confocal Microscope (Carl Zeiss, Jena, Germany) with the same pinhole setting, pixel format (1024 31024), and scanning data depth (0.8 mm). Double fluorescence for green and red channels was imaged by excitation of argon-HeNe1 at wavelengths of 488 and 530 nm. Fifty high-power fields from each animal were analyzed by imaging processing software (Volocity 3.0; Improvision, Lexington, Mass). High intensity of red and green (above 551 voxels) was regarded as specific immunoreactive signals. The red (COX IV) was set as reference signal and the contribution of the green (cytochrome c) to the colocalization of the both signals was quantified as the overlap coefficient (Kx-green) and used to compare the diffusion of cytochrome c staining between groups. 21 Terminal Deoxynucleotidyl Transferase-mediated dUTP Nick End Labeling (TUNEL) Staining OCT-embedded transverse ventricular slices were cut into 5-mm serial sections. TUNEL staining was performed with the In Situ Cell Death Detection Kit (Roche Diagnostics, Indianapolis, Ind) according to the manufacturer's instructions. After TUNEL, all nuclei were counterstained with 4,6-diamino-2-phenylindole. TUNELpositive myocytes and the number of total myocytes were counted in 50 random high-power fields (3600) with a Leica (Deerfield, Ill) fluorescent microscope and OpenLab software (Improvision, Lexington, Mass). Approximately 10,000 myocytes were examined from at least three different slices from each animal.
Statistics
Data are expressed as mean 6 SEM and group comparisons made with the Fisher least significant difference analysis of variance. A Tukey test was used for multiple post hoc comparisons. 
Results
Mitochondrial Bax Translocation CCP was associated with Bax translocation to the mitochondria (homodimer) in the mitochondrial protein fraction when compared with the non-CCP myocardium (1.60 6 0.02 vs 1.43 6 0.30 arbitrary units, P , .01). Bax translocation was reduced after CsA treatment (1.47 6 0.04 arbitrary units; P , .05 vs CCP) to the levels that were similar to non-CCP (Figure 1 ).
Mitochondrial Permeabilization and Cytochrome c Release
Fluorescence immunohistochemistry was used to compare patterns of cytochrome c and COX IV staining (Figure 2) . Release of cytochrome c from the mitochondria causes diffusion of the cytochrome c staining in the cytoplasm and a stippled green pattern is produced. This pattern is prominent in the merged images from the CCP myocardium, whereas in non-CCP and CCP1CsA myocardium, only faint diffusion Figure 2 . A, Immunofluorescence of cytochrome c oxidase IV (COX IV) and cytochrome c in the myocardium from non-CCP, CCP, and CCP1CsA myocardium. In each panel, COX IV (mitochondria) is stained red, cytochrome c is stained green, and the merged mages are shown. Superimposition of red and green staining results in a brownish color that suggests retention of cytochrome c in the non-CCP and CCP1CsA mitochondria. A fine diffuse green staining can be seen in the merged images of CCP myocardium, suggesting mitochondrial release of cytochrome c. Scatterplots display the distribution of red and green voxels in the merge images of non-CCP, CCP, and CCP1CsA, as well as the various degrees of colocalization as shown in orange and yellow. B, Quantification of the overlap coefficient (Kx-green) in the merge images for non-CCP, CCP, and CCP1CsA groups is shown. *P < .01 versus non-CCP; #P < .01 versus CCP. For abbreviations, see Figure 1 .
of cytochrome c staining in the merged images was found. The contribution of the green color intensity to the colocalization of these color voxels in the merged images was quantified by overlap coefficients (Kx-green). Compared with non-CCP and CCP1CsA myocardium, lower overlap coefficient (Kx-green) was found in CCP myocardium (P , .01).
TUNEL Staining
TUNEL-positive nuclei were more frequent in CCP myocardium than in non-CCP and CCP1CsA myocardium (22.5 6 4.5 vs 3.0 6 1.3 and 4.0 6 2.2 per 10,000 nuclei; P , .01) (Figure 3 ). There was no difference between non-CCP and CCP1CsA groups (P 5 .82).
Clark-electrode Oxygen Consumption Measurements
Isolated mitochondrial oxygen consumption was assessed during state 2 respiration for mitochondrial complexes I, II, and IV and was not different among groups, suggesting comparable levels of mitochondrial integrity after fractionation. Cardioplegic arrest was associated with diminished state 3 respiration, and the decrement of state 3 and the ratio of state 3 to state 2 was prevented by pretreatment with CsA (P , .01) (Figure 4 and Table 1 ). Complex II and complex IV oxygen consumption rates were not different between groups.
Myocardial Performance
There was no significant different change in heart rate among non-CCP, CCP, and CCP1CsA. LV developed systolic pressure and 6dP/dtmax were significantly depressed at 5, 15, 30, and 60 minutes of reperfusion in the CCP hearts (compared with non-CCP). LV end-diastolic pressure was significantly increased in CCP when compared with non-CCP. In contrast, administration of CsA improved all these parameters (Table 2 and Figure 5 ).
Discussion
A typical pathologic change in the postischemic myocardium after cardioplegic arrest is manifest by a constellation of apoptotic events 19 and apoptosis-related alterations in mitochondrial structure and function including Bax translocation, mitochondrial permeabilization, cytochrome c release, and deficits in mitochondrial electron transport. 8, 9 We have previously defined this constellation of events as ARMD. The current study demonstrates that pretreatment with CsA, an MPTP inhibitor, prevents ARMD and this prevention is associated with preservation of global myocardial performance.
The etiology of mitochondrial permeabilization during apoptosis is not fully determined. Bax translocation, however, is associated with disruption of outer mitochondrial membrane integrity and cytochrome c release into the cytoplasm. The mechanism by which Bax induces the permeabilization is not clearly defined, and it may act through direct pore-forming capacity 22 or through direct interaction with the MPTP. 23 Alternatively, transient MPTP opening may act as an initial event to stimulate Bax translocation to the mitochondria 24 and, through a positive feedback loop between Bax and the MPTP, stimulate further permeabilization and cytochrome c release. 25 In the present study, CsA prevented Bax translocation, suggesting that MPTP opening is an ''upstream'' signaling event that is required for Bax translocation and subsequent mitochondrial permeabilization. Cytochrome c is an important component of mitochondrial oxidative phosphorylation. A relative deficiency of mitochondrial cytochrome c, as may occur after mitochondrial permeabilization, may be responsible for deficits in mitochondrial respiration. 2 The immunohistochemistry data in the current study are consistent with diffusion of cytochrome c from the mitochondria into the cytosol owing to permeabilization of the outer mitochondrial membrane. Cytochrome c release from mitochondria inhibits mitochondrial respiration owing to limitation of electron transport to cytochrome c oxygenase, 26 and cytochrome c release, in turn, stimulates mitochondrial superoxide formation that may amplify the deficits in electron transport chain activity. 27 In addition to these upstream apoptotic signals, Ricci, Gottlieb, and Grier 28 reported that caspase 3, a ''downstream'' protease activated by cytochrome c release, can directly inhibit electron transport chain activity. In the present study, the prevention of mitochondrial permeabilization with CsA was associated with preservation of mitochondrial function at complex I, suggesting that loss of reducing equivalents (cytochrome c) or direct inhibition of electron transport can be prevented with maintenance of mitochondrial outer membrane integrity.
Other investigators have demonstrated that inhibition of mitochondrial dysfunction results in the preservation of myocardial function. 29, 30 Specific inhibition of the MPTP by CsA improves recovery of cardiac function and is associated with reduction of cell death in a variety of in vivo and in vitro ischemia/reperfusion models. 17, 30 Therefore, a rationale is provided for a myopreservation strategy focused on maintenance of mitochondrial structural and functional integrity 17, 31 In the current study, cardioplegic arrest induced conspicuous apoptosis-related alterations in mitochondrial structure and function, and these changes were correlated with myocardial dysfunction. Pretreatment with CsA prevents both ARMD and myocardial dysfunction, supporting a causal relationship between ARMD and global myocardial dysfunction.
Evidence for completion of apoptosis is supported by the increased prevalence of TUNEL-positive nuclei after cardioplegic arrest and abrogation of this finding with cyclosporine. It is important, however, to recognize that positive TUNEL staining is not restricted to apoptotic nuclei and false positive results can occur after stimuli that promote DNA injury (eg, necrosis). We 5, 6 have previously demonstrated that cardioplegic arrest is associated with DNA laddering, cleavage of caspase 3, and absence of necrosis, which supports the relationship between TUNEL positivity and apoptosis in the current model.
Conclusions
Inhibition of MPTP opening with CsA prevents ARMD and preserves cardiac global performance after cardioplegic arrest. Better understanding of the interaction between apoptotic signals and ARMD and the correlation of ARMD with myocardial dysfunction will enhance myopreservative strategies for the cardiac surgeon.
